Suppression of polyglutamine-induced toxicity in cell and animal models of Huntington's disease by ubiquilin

By Wang Hongmin   Lim Precious J.   Vogel Bruce E.   Monteiro Mervyn J.  

Human Molecular Genetics, Vol. 15, Iss. 6, 2006-03 ,pp. : 1025-1041

Oxford University Press

Access to resources Recommend Favorite

Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease

By Rose Claudia   Menzies Fiona M.   Renna Maurizio   Acevedo-Arozena Abraham   Corrochano Silvia   Sadiq Oana   Brown Steve D.   Rubinsztein David C.  

Human Molecular Genetics, Vol. 19, Iss. 11, 2010-06 ,pp. : 2144-2153

Oxford University Press

Access to resources Recommend Favorite

A Drosophila model of FUS-related neurodegeneration reveals genetic interaction between FUS and TDP-43

By Lanson Nicholas A.   Maltare Astha   King Hanna   Smith Rebecca   Kim Ji Han   Taylor J. Paul   Lloyd Thomas E.   Pandey Udai Bhan  

Human Molecular Genetics, Vol. 20, Iss. 13, 2011-07 ,pp. : 2510-2523

Oxford University Press

Access to resources Recommend Favorite

Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease

By Chan Edmond Y.W.  

Human Molecular Genetics, Vol. 11, Iss. 17, 2002-06 ,pp. : 1939-1951

Oxford University Press

Access to resources Recommend Favorite

Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects

By Borchelt D.R.  

Human Molecular Genetics, Vol. 11, Iss. 17, 2002-06 ,pp. : 1927-1937

Oxford University Press

Access to resources Recommend Favorite